organophosphonates has been researched along with Graft vs Host Disease in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Boeckh, MJ; Brundage, TM; Hill, JA; Lanier, R; Marty, FM; Nichols, WG; Papanicolaou, GA; Zerr, DM | 1 |
| Cardona, DM; Detweiler, CJ; Mueller, SB; Prasad, VK; Saullo, JL; Sung, AD | 1 |
| Ader, F; Barraco, F; Billaud, G; Chidiac, C; Detrait, M; Ducastelle-Leprêtre, S; Ferry, T; Gilis, L; Labussière-Wallet, H; Michallet, M; Morisset, S; Nicolini, FE; Salles, G; Sobh, M; Tedone, N; Thomas, X | 1 |
| Bilius, V; Pasauliene, R; Rageliene, L; Rascon, J; Verkauskas, G; Zubka, V | 1 |
| Hartline, CB; Larson, RA; Mommeja-Marin, H; Mullane, KM; Nuss, C; Prichard, MN; Ridgeway, J; Theusch, J | 1 |
| Benninghoff, U; Friedrich, W; Hönig, M; Schulz, A; Schütz, C | 1 |
| Borchert, K; Freund, M; Hilgendorf, I; Junghanss, C; Loebermann, M; Schmitt, M | 1 |
| Boeckh, M; Nichols, WG; Papanicolaou, G; Rubin, R; Wingard, JR; Zaia, J | 1 |
| Bailey, AS; Carr, TF; Coussons, M; Grainger, JD; Guiver, M; Khalid, T; Mutton, KJ; Sivaprakasam, P; Turner, AJ; Wynn, RF | 1 |
| Bornhäuser, M; Ehninger, G; Illmer, T; Jacobs, E; Kiani, A; Pöhlmann, C; Reuner, U; Rohayem, J; Schetelig, J | 1 |
| Elleder, D; Elleder, M; Kren, V; Otová, B; Panczak, A; Sladká, M | 1 |
| Elleder, D; Elleder, M; Holý, A; Kren, V; Otová, B; Panczak, A | 1 |
| Boeckh, M; Chuang, EL; Corey, L; Crippa, F; Sale, G | 1 |
| Bordigoni, P; Carret, AS; Corsaro, D; Dauendorffer, JN; Edert, D; Le Faou, A; Venard, V | 1 |
| Ait Arkoub, Z; Arnulf, B; Chebbi, F; Fillet, AM; Lefrere, F; Varet, B | 1 |
| Chakrabarti, S; Collingham, KE; Fegan, CD; Milligan, DW; Osman, H | 1 |
1 review(s) available for organophosphonates and Graft vs Host Disease
| Article | Year |
|---|---|
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.
Topics: Acyclovir; Antigens, CD34; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunotherapy; Lymphocyte Depletion; Organophosphonates; Organophosphorus Compounds; Transplantation Conditioning | 2003 |
15 other study(ies) available for organophosphonates and Graft vs Host Disease
| Article | Year |
|---|---|
Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Cohort Studies; Cytosine; DNA, Viral; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Herpesvirus 6, Human; Humans; Incidence; Male; Middle Aged; Organophosphonates; Prognosis; Randomized Controlled Trials as Topic; Roseolovirus Infections; United States; Viral Load; Viremia; Virus Activation; Young Adult | 2020 |
Brincidofovir (CMX001) Toxicity Associated With Epithelial Apoptosis and Crypt Drop Out in a Hematopoietic Cell Transplant Patient: Challenges in Distinguishing Drug Toxicity From GVHD.
Topics: Adenoviridae; Adenoviridae Infections; Autografts; Child, Preschool; Colon; Cytosine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma; Octreotide; Organophosphonates; Viremia | 2018 |
High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Female; Graft vs Host Disease; Health Care Costs; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Incidence; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Risk Factors; Transplantation, Homologous; Tumor Virus Infections; Viremia; Young Adult | 2014 |
Intravesical cidofovir to treat BK virus-associated hemorrhagic cystitis in children after hematopoietic stem cell transplantation.
Topics: Administration, Intravesical; Adolescent; Antiviral Agents; BK Virus; Child; Cidofovir; Cystitis; Cytosine; Female; Formaldehyde; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Immune System; Male; Organophosphonates; Polymerase Chain Reaction; Polyomavirus Infections; Time Factors | 2015 |
Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.
Topics: Acyclovir; Adult; Antibiotic Prophylaxis; Antineoplastic Agents; Antiviral Agents; Cytosine; Drug Resistance, Viral; Drugs, Investigational; Female; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Herpesvirus 3, Human; Humans; Immunocompromised Host; Investigational New Drug Application; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Organophosphonates; Transplantation, Homologous; Valacyclovir; Valine | 2016 |
Results and long-term outcome in 39 patients with Wiskott-Aldrich syndrome transplanted from HLA-matched and -mismatched donors.
Topics: Antiviral Agents; Child; Child, Preschool; Chimerism; Cidofovir; Cyclosporine; Cytosine; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Living Donors; Male; Organophosphonates; Treatment Failure; Wiskott-Aldrich Syndrome | 2009 |
Tenofovir for treatment of hepatitis B virus reactivation in patients with chronic GVHD.
Topics: Adenine; Adult; Chronic Disease; Female; Graft vs Host Disease; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Virus Activation | 2011 |
Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention.
Topics: Adenovirus Infections, Human; Adolescent; Antiviral Agents; Blood; Bronchoalveolar Lavage Fluid; Child; Cidofovir; Cytosine; Feces; Female; Fluorescent Antibody Technique; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Infant; Male; Microscopy, Electron, Transmission; Organophosphonates; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin | 2007 |
Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient.
Topics: Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Encephalitis, Viral; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpesvirus 6, Human; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Organophosphonates; Roseolovirus Infections; Viral Load | 2007 |
Model of acute graft-vs-host-disease in adult (SHR x BN.lx)F1 rats and its inhibition by adenine analog.
Topics: Adenine; Animals; Bone Marrow Transplantation; Disease Models, Animal; Female; Graft vs Host Disease; Hybridization, Genetic; Immunosuppressive Agents; Male; Organophosphonates; Rats; Rats, Inbred BN; Rats, Inbred SHR; Transplantation, Homologous | 1993 |
Prevention of acute graft-versus-host disease in rats using 9-(2-phosphonomethoxyethyl) adenine (PMEA).
Topics: Acute Disease; Adenine; Animals; Disease Models, Animal; Female; Graft vs Host Disease; Immunosuppressive Agents; Immunotherapy; Injections, Intraperitoneal; Organophosphonates; Rats; Rats, Inbred BN; Rats, Inbred SHR | 1993 |
Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
Topics: Adult; Antiviral Agents; Chronic Disease; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Risk Factors; Treatment Outcome; Virus Activation | 2001 |
Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Acute Disease; Acyclovir; Adolescent; Amino Acid Substitution; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Codon; Cytosine; DNA Mutational Analysis; Drug Resistance, Viral; Female; Foscarnet; Graft vs Host Disease; Herpes Simplex; Humans; Immunocompromised Host; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Mutation, Missense; Organophosphonates; Organophosphorus Compounds; Point Mutation; Salvage Therapy; Simplexvirus; Thymidine Kinase; Transplantation, Homologous; Valacyclovir; Valine; Viral Proteins; Virus Activation | 2001 |
Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
Topics: Acyclovir; Antineoplastic Agents, Alkylating; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Combined Modality Therapy; Cyclosporine; Cytarabine; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Fatal Outcome; Foscarnet; Graft vs Host Disease; Herpes Genitalis; Herpes Simplex; Humans; Hydroxyurea; Immunocompromised Host; Immunosuppressive Agents; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Transplantation Conditioning; Whole-Body Irradiation | 2001 |
Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
Topics: Adult; Antiviral Agents; Cidofovir; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Drug Evaluation; Eye Infections, Viral; Female; Foscarnet; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Probenecid; Recurrence; Safety; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Uveitis, Anterior; Viral Load; Viremia; Vomiting | 2001 |